Stay updated on Brexanolone in COVID-19 ARDS Clinical Trial
Sign up to get notified when there's something new on the Brexanolone in COVID-19 ARDS Clinical Trial page.

Latest updates to the Brexanolone in COVID-19 ARDS Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe ClinicalTrials.gov record for the brexanolone study in COVID-19-related ARDS is displayed, with study details and results information. The previous access-denied page is no longer shown.SummaryDifference49%

- Check20 days agoChange DetectedThe ClinicalTrials.gov footer revision label changed from v3.7.2 to v3.8.0, while the page continued to show a 403 Forbidden error.SummaryDifference0.2%

- Check27 days agoChange DetectedA sitewide banner announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology and links to updates and FAQs.SummaryDifference1%

- Check34 days agoChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check41 days agoChange DetectedThe 403 Forbidden page’s footer revision identifier changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check55 days agoChange DetectedThe change introduces a 403 Forbidden page, replacing the expected study content with an access-denied message and standard footer. This signals restricted access rather than an update to study information.SummaryDifference0.5%

Stay in the know with updates to Brexanolone in COVID-19 ARDS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Brexanolone in COVID-19 ARDS Clinical Trial page.